miércoles, 23 de diciembre de 2015

FDA Press Releases Update ► FDA approves Zurampic to treat high blood uric acid levels associated with gout

12/22/2015 06:00 PM EST
The U.S. Food and Drug Administration today approved Zurampic (lesinurad) to treat high levels of uric acid in the blood (hyperuricemia) associated with gout, when used in combination with a xanthine oxidase inhibitor (XOI), a type of drug approved to reduce the production of uric acid in the body.

No hay comentarios:

Publicar un comentario